Prep Biopharm Limited   Report issue

For profit Phase 1 Phase 2
Founded: London United Kingdom (2015)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2015
NCT03220048
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Prep Biopharm Limited

Active Ingredients

Drugs in Phase 2 Trials (2)

corn (2 trials)

poly-iclc (1 trial)

Drugs in Phase 1 Trials (2)

polyribocytidylic acid (1 trial)

polyriboinosinic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Influenza, Human (Phase 2)

Respiratory Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4